like-To The Moon - Tiger Brokers Online Investing Community

4
Comment
Favorite

ycheong
2022-04-09

US IPO Weekly Recap: The Second Quarter Starts With No IPOs

There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial f

US IPO Weekly Recap: The Second Quarter Starts With No IPOs

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

Top
Latest

No comments yet

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":9015663791,"tweetId":"9015663791","gmtCreate":1649473514515,"gmtModify":1676534518391,"author":{"id":4101515922371630,"idStr":"4101515922371630","authorId":4101515922371630,"authorIdStr":"4101515922371630","name":"ycheong","avatar":"https://static.tigerbbs.com/e72f54521a5b0b85fdb76102b268baa3","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>like</p></body></html>","htmlText":"<html><head></head><body><p>like</p></body></html>","text":"like","highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/9015663791","repostId":1190868678,"repostType":4,"repost":{"id":"1190868678","pubTimestamp":1649462070,"share":"https://www.laohu8.com/m/news/1190868678?lang=&edition=full","pubTime":"2022-04-09 07:54","market":"us","language":"en","title":"US IPO Weekly Recap: The Second Quarter Starts With No IPOs","url":"https://stock-news.laohu8.com/highlight/detail?id=1190868678","media":"Renaissance Capital","summary":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial f","content":"<html><head></head><body><p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.</p><p>The week’s sole deal was <b>Denali Capital Acquisition</b>(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.</p><p>Three IPOs submitted initial filings. Norovirus vaccine developer <b>HilleVax</b>(HLVX) filed to raise $100 million. Eye disease biotech <b>Belite Bio</b>(BLTE) filed to raise $46 million, inflammatory disease biotech <b>Intrinsic Medicine</b>(INRX) filed to raise $29 million, and projection screen maker <b>Strong Global Entertainment</b>(SGE) filed to raise $16 million.</p></body></html>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: The Second Quarter Starts With No IPOs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: The Second Quarter Starts With No IPOs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-09 07:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DECAU":"Denali Capital Acquisition Corp"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190868678","content_text":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.Three IPOs submitted initial filings. Norovirus vaccine developer HilleVax(HLVX) filed to raise $100 million. Eye disease biotech Belite Bio(BLTE) filed to raise $46 million, inflammatory disease biotech Intrinsic Medicine(INRX) filed to raise $29 million, and projection screen maker Strong Global Entertainment(SGE) filed to raise $16 million.","news_type":1},"isVote":1,"tweetType":1,"viewCount":496,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}